SCIENCE IN Current Ratio vs. Shares Outstanding

8D9 Stock  EUR 0.30  0.01  3.45%   
Considering SCIENCE IN's profitability and operating efficiency indicators, SCIENCE IN SPORT may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess SCIENCE IN's ability to earn profits and add value for shareholders.
For SCIENCE IN profitability analysis, we use financial ratios and fundamental drivers that measure the ability of SCIENCE IN to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well SCIENCE IN SPORT utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between SCIENCE IN's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of SCIENCE IN SPORT over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between SCIENCE IN's value and its price as these two are different measures arrived at by different means. Investors typically determine if SCIENCE IN is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SCIENCE IN's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

SCIENCE IN SPORT Shares Outstanding vs. Current Ratio Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining SCIENCE IN's current stock value. Our valuation model uses many indicators to compare SCIENCE IN value to that of its competitors to determine the firm's financial worth.
SCIENCE IN SPORT is number one stock in current ratio category among its peers. It also is number one stock in shares outstanding category among its peers creating about  76,292,035  of Shares Outstanding per Current Ratio. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SCIENCE IN's earnings, one of the primary drivers of an investment's value.

SCIENCE Shares Outstanding vs. Current Ratio

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

SCIENCE IN

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
2.26 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

SCIENCE IN

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
172.42 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

SCIENCE Shares Outstanding Comparison

SCIENCE IN is currently under evaluation in shares outstanding category among its peers.

SCIENCE IN Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in SCIENCE IN, profitability is also one of the essential criteria for including it into their portfolios because, without profit, SCIENCE IN will eventually generate negative long term returns. The profitability progress is the general direction of SCIENCE IN's change in net profit over the period of time. It can combine multiple indicators of SCIENCE IN, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, and sports and fitness enthusiasts. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom. SCIENCE IN is traded on Frankfurt Stock Exchange in Germany.

SCIENCE Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on SCIENCE IN. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of SCIENCE IN position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the SCIENCE IN's important profitability drivers and their relationship over time.

Use SCIENCE IN in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SCIENCE IN position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCIENCE IN will appreciate offsetting losses from the drop in the long position's value.

SCIENCE IN Pair Trading

SCIENCE IN SPORT Pair Trading Analysis

The ability to find closely correlated positions to SCIENCE IN could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SCIENCE IN when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SCIENCE IN - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SCIENCE IN SPORT to buy it.
The correlation of SCIENCE IN is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SCIENCE IN moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SCIENCE IN SPORT moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SCIENCE IN can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your SCIENCE IN position

In addition to having SCIENCE IN in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Housewares Thematic Idea Now

Housewares
Housewares Theme
Companies making housewares accessories and providing houseware services. The Housewares theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Housewares Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in SCIENCE Stock

To fully project SCIENCE IN's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of SCIENCE IN SPORT at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include SCIENCE IN's income statement, its balance sheet, and the statement of cash flows.
Potential SCIENCE IN investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although SCIENCE IN investors may work on each financial statement separately, they are all related. The changes in SCIENCE IN's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on SCIENCE IN's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.